Biology Reference
In-Depth Information
143.
Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved
in oxidative phosphorylation are coordinately downregulated in human diabetes.
Nat
Genet
. 2003;34:267-
273.
144.
Xu L, Furlotte N, Lin Y, et al. Functional cohesion of gene sets determined by latent
semantic indexing of PubMed abstracts.
PLoS One
. 2011;6:e18851.
145.
Chadwick W, Keselman A, Park SS, et al. Repetitive peroxide exposure reveals pleio-
tropic mitogen-activated protein kinase signaling mechanisms.
J Signal Transduct
.
2011;2011:636951.
146.
Lima-Fernandes E, Enslen H, Camand E, et al. Distinct functional outputs of PTEN
signalling are controlled by dynamic association with
b
-arrestins.
EMBO J
.
2011;30:2557-
2568.
147.
Klewe IV, Nielsen SM, Tarpø L, et al. Recruitment of beta-arrestin2 to the dopamine
D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.
Neuropharmacology
. 2008;54:1215
-
1222.
148.
Xiao K, Sun J, Kim J, et al. Global phosphorylation analysis of beta-arrestin-mediated
signaling downstream of a seven transmembrane receptor (7TMR).
Proc Natl Acad Sci
USA
. 2010;107:15299-
15304.
149.
Xiao K, McClatchy DB, Shukla AK, et al. Functional specialization of beta-arrestin
interactions revealed by proteomic analysis.
Proc Natl Acad Sci USA
. 2007;104:
12011-
12016.
150.
Rose RH, Briddon SJ, Holliday ND. Bimolecular fluorescence complementation: light-
ing up seven transmembrane domain receptor signalling networks.
Br J Pharmacol
.
2010;159:738
-
750.
151.
Zimmerman B, Beautrait A, Aguila B, et al. Differential
b
-arrestin-dependent confor-
mational signaling and cellular responses revealed by angiotensin analogs.
Sci Signal
.
2012;5:ra33.
152.
Emery AC, DiRaddo JO, Miller E, et al. Ligand bias at metabotropic glutamate 1a
receptor: molecular determinants that distinguish
b
-arrestin from G protein-mediated
signaling.
Mol Pharmacol
. 2012;82:291-
301.
153.
Cottingham C, Chen Y, Jiao K, Wang Q. The antidepressant desipramine is an
arrestin-biased ligand at the
a
(2A)-adrenergic receptor driving receptor down-
regulation in vitro and in vivo.
J Biol Chem
. 2011;286:36063-
36075.
154.
Allen JA, Yost JM, Setola V, et al. Discovery of
b
-arrestin-biased dopamine D2 ligands
for probing signal transduction pathways essential for antipsychotic efficacy.
Proc Natl
Acad Sci USA
. 2011;108:18488-
18493.
155.
Bl¨ttermann S, Peters L, Ottersbach PA, et al. A biased ligand for OXE-R uncouples
G
a
and G
b
g
signaling within a heterotrimer.
Nat Chem Biol
. 2012;8:631
-
638.
156.
Watts DJ, Strogatz SH. Collective dynamics of
'small-world' networks.
Nature
.
1998;393:440-
442.
157.
Schadt EE, Zhang B, Zhu J. Advances in systems biology are enhancing our under-
standing of disease and moving us closer to novel disease treatments.
Genetica
.
2009;136:259-
269.
158.
Schadt EE. Molecular networks as sensors and drivers of common human diseases.
Nature
. 2009;461:218-
223.
Previous Page
Next Page
Progress in Molecular Biology and Translational Science
Search WWH ::
Custom Search
Home